লোডিং...
Clinical analysis of bevacizumab targeting therapy in treating early colorectal carcinoma after operation
Clinical effects of bevacizumab target therapy in treating early colorectal carcinoma (CRC) after resection were analyzed. Ninety-two patients diagnosed with early CRC and treated with endoscopic mucosal resection for the first time were selected for the study. They were randomly divided into the co...
সংরক্ষণ করুন:
| প্রকাশিত: | Oncol Lett |
|---|---|
| প্রধান লেখক: | , , , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
D.A. Spandidos
2017
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5452938/ https://ncbi.nlm.nih.gov/pubmed/28599469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6087 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|